Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view

Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent metabolic disorder with steadily increasing incidence rates worldwide, especially in the West. There are no drugs available at present to treat NAFLD, and the primary therapeutic options include weight loss and the combination of health...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hui-Ting, Huang, Hong-Li, Li, Yong-Qiang, Xu, Hao-Ming, Zhou, Yong-Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201149/
https://www.ncbi.nlm.nih.gov/pubmed/32390701
http://dx.doi.org/10.3748/wjg.v26.i16.1901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201149/
https://www.ncbi.nlm.nih.gov/pubmed/32390701
http://dx.doi.org/10.3748/wjg.v26.i16.1901

Ejemplares similares